About
Directors
Management
SAB
Pipeline
MM-398
MM-121
MM-151
MM-111
MM-302
R&D
News & Events
Publications
Investor Relations
Careers
Contact
Terms and Conditions
Directions
Home
»
Information
»
Phase 1 Data on MM-398 will be Presented at the ASCO 2012 Gastrointestinal Cancers Symposium
Phase 1 Data on MM-398 will be Presented at the ASCO 2012 Gastrointestinal Cancers Symposium
January 12, 2012 - Posted in
Information
«
Merrimack Pharmaceuticals Initiates Enrollment in Phase 1 Study of MM-151 in Patients with Refractory Advanced Solid Tumors